Claret Asset Management Corp
Position in CRL — Charles River Laboratories International, Inc.
CIK 1735513
MONTREAL, A8
Position in CRL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$226,790
-$36,272 QoQ
Shares Held
1,000
-34.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#391
of 564 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Claret Asset Management Corp holds $3,109,631 across 10 Diagnostics & Research names. CRL ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
4,254 | $821,957 | |
| 2 | WAT |
Waters Corp /De/
|
1,030 | $386,291 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
626 | $313,851 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
183 | $233,784 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
434 | $228,474 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,000 | $226,790 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,698 | $225,545 | |
| 8 | DGX |
Quest Diagnostics Inc
|
1,061 | $224,878 |
All Filings in CRL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,790 | 1,000 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $263,062 | 1,525 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $304,207 | 1,525 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $239,070 | 1,528 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $235,181 | 1,550 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||